arrow
E

Emily F. Mason

pennsylvania commonwealth system of higher education (pcshe)
H指数:16
被引数:4,260

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Characterization of chromosome 5 aberrations in TP53 mutated myeloid neoplasms with ≥5% blasts: An International TP53 Investigators Network (iTiN) study

TP53突变髓系肿瘤中≥5%原始细胞染色体5异常的表征:一项国际TP53研究者网络(iTiN)研究

Cancer
IF5.1
2026-01-010
OAAI
Impact of Co-Mutations, Monocytic Differentiation, and Choice of Hypomethylating Agent Combined with Venetoclax on the Predictive Value of Molecular Prognostic Risk Signature in Newly Diagnosed AML Patients

Co-突变、单核细胞分化以及低甲基化药物选择与Venetoclax联合对初诊AML患者分子预后风险特征预测价值的影响

BLOOD
IF23.1
2024-11-050
PRE
LAIR-1 agonism as a therapy for acute myeloid leukemia
2023-11-155
OAAI
TP53 Mutations Are Associated with Increased Infections and Reduced Hematopoietic Cell Transplantation Rates in Myelodysplastic Syndrome and Acute Myeloid Leukemia

TP53突变与骨髓增生异常综合征和急性髓系白血病的感染增加和造血细胞移植率降低有关

2023-06-015
OAAI
PI3K Inhibition Restores and Amplifies Response to Ruxolitinib in Patients with Myelofibrosis
2023-04-103
OA